OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Effectiveness of Switching Biologics for Severe Asthma Patients in Japan: A Single-Center Retrospective Study
Takanori Numata, Jun Araya, Hanae Miyagawa, et al.
Journal of Asthma and Allergy (2021) Vol. Volume 14, pp. 609-618
Open Access | Times Cited: 37
Takanori Numata, Jun Araya, Hanae Miyagawa, et al.
Journal of Asthma and Allergy (2021) Vol. Volume 14, pp. 609-618
Open Access | Times Cited: 37
Showing 26-50 of 37 citing articles:
Real-World Clinical Outcomes in Asthmatic Patients Switched from Omalizumab to Anti-Interleukin-5 Therapy
Emily O’Reilly, Deborah Casey, Hisham Ibrahim, et al.
Journal of Asthma and Allergy (2022) Vol. Volume 15, pp. 935-937
Open Access | Times Cited: 5
Emily O’Reilly, Deborah Casey, Hisham Ibrahim, et al.
Journal of Asthma and Allergy (2022) Vol. Volume 15, pp. 935-937
Open Access | Times Cited: 5
Biological therapy for severe asthma – Indian perspectives and challenges
Rajesh Venkitakrishnan, Jolsana Augustine, Divya Ramachandran, et al.
Lung India (2023) Vol. 40, Iss. 3, pp. 253-259
Open Access | Times Cited: 2
Rajesh Venkitakrishnan, Jolsana Augustine, Divya Ramachandran, et al.
Lung India (2023) Vol. 40, Iss. 3, pp. 253-259
Open Access | Times Cited: 2
Impact of benralizumab on asthma exacerbation-related medical healthcare resource utilization and medical costs: results from the ZEPHYR 2 study
Yen Chung, Diego J. Maselli, Fan Mu, et al.
Journal of Medical Economics (2023) Vol. 26, Iss. 1, pp. 954-962
Open Access | Times Cited: 2
Yen Chung, Diego J. Maselli, Fan Mu, et al.
Journal of Medical Economics (2023) Vol. 26, Iss. 1, pp. 954-962
Open Access | Times Cited: 2
Anti–IL-4R versus anti–IL-5/5R after anti–IL-5/5R failure in asthma: An emulated target trial
S. Valéry, Noëmie Simon, Gilles Devouassoux, et al.
Journal of Allergy and Clinical Immunology (2024) Vol. 154, Iss. 4, pp. 922-932
Open Access
S. Valéry, Noëmie Simon, Gilles Devouassoux, et al.
Journal of Allergy and Clinical Immunology (2024) Vol. 154, Iss. 4, pp. 922-932
Open Access
Real-life effectiveness of dupilumab in patients with mild to moderate bronchial asthma comorbid with CRSwNP
Shunsuke Minagawa, Jun Araya, Naoaki Watanabe, et al.
Research Square (Research Square) (2022)
Open Access | Times Cited: 2
Shunsuke Minagawa, Jun Araya, Naoaki Watanabe, et al.
Research Square (Research Square) (2022)
Open Access | Times Cited: 2
Switching Biological Therapies in Adults with Severe Asthma: What Are the Dilemmas and Is It Worthwhile?
John D. Politis, Philip G. Bardin
Annals of the American Thoracic Society (2022) Vol. 19, Iss. 12, pp. 1965-1970
Closed Access | Times Cited: 2
John D. Politis, Philip G. Bardin
Annals of the American Thoracic Society (2022) Vol. 19, Iss. 12, pp. 1965-1970
Closed Access | Times Cited: 2
Use of biologics for the treatment of moderate-to-severe asthma: the age of personalized medicine
S. Shahzad Mustafa, Sara Patrawala, Sandhya Khurana
Current Opinion in Pulmonary Medicine (2022) Vol. 28, Iss. 3, pp. 266-273
Closed Access | Times Cited: 1
S. Shahzad Mustafa, Sara Patrawala, Sandhya Khurana
Current Opinion in Pulmonary Medicine (2022) Vol. 28, Iss. 3, pp. 266-273
Closed Access | Times Cited: 1
The association of varying treatment thresholds of mepolizumab on asthma exacerbations in adults
Jaclyn Davis, Pamela M. McMahon, Andrew Simon, et al.
Journal of Asthma (2023) Vol. 60, Iss. 12, pp. 2198-2206
Closed Access
Jaclyn Davis, Pamela M. McMahon, Andrew Simon, et al.
Journal of Asthma (2023) Vol. 60, Iss. 12, pp. 2198-2206
Closed Access
Addressing therapeutic inertia for asthma biologics: Lessons from the KOFU study
Tsutomu Tamada, Hisatoshi Sugiura
Respiratory Investigation (2023) Vol. 61, Iss. 6, pp. 815-823
Open Access
Tsutomu Tamada, Hisatoshi Sugiura
Respiratory Investigation (2023) Vol. 61, Iss. 6, pp. 815-823
Open Access
Monitoring and Evaluation of Therapeutic Response in Patients with Severe Asthma on Biologics
Sanda Škrinjarić Cincar
(2013), pp. 63-75
Open Access
Sanda Škrinjarić Cincar
(2013), pp. 63-75
Open Access
Biological Therapy in Refractory Chronic Rhinosinusitis with Nasal Polyp
Seung Koo Yang, Dae Woo Kim
Journal of Clinical Otolaryngology Head and Neck Surgery (2022) Vol. 33, Iss. 2, pp. 44-52
Open Access
Seung Koo Yang, Dae Woo Kim
Journal of Clinical Otolaryngology Head and Neck Surgery (2022) Vol. 33, Iss. 2, pp. 44-52
Open Access
